Advanced search
Publication Cover
Microcirculation Volume 5, 1998 - Issue 2-3
Submit an article Journal homepage
5
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Increased Apoptosis Coincides with Onset of Involution in Infantile Hemangioma

MARIA J. RAZON Surgical Research Laboratory, Children's Hospital and Harvard Medical School, Boston, MA, USA
,
BIRGIT M. KRÄLING Surgical Research Laboratory, Children's Hospital and Harvard Medical School, Boston, MA, USA; Department of Surgery, Children's Hospital and Harvard Medical School, Boston, MA, USA
,
JOHN B. MULLIKEN Division of Plastic Surgery, Children's Hospital and Harvard Medical School, Boston, MA, USA; Department of Surgery, Children's Hospital and Harvard Medical School, Boston, MA, USA
&
JOYCE BISCHOFF Surgical Research Laboratory, Children's Hospital and Harvard Medical School, Boston, MA, USA; Department of Surgery, Children's Hospital and Harvard Medical School, Boston, MA, USA
Pages 189-195 | Published online: 10 Jul 2009

References

  • Alon T, Hemo I, Itin A, Pe'er J, Stone J, Keshet, E. (1995). Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Na-ture Med 1:1024–1028.
  • Augustin HG, Braun K, Telemenakis I, Modlich U, Kuhn W. (1995). Ovarian angiogenesis: Phenotypic characterization of endothelial cells in a physiological model of blood vessel growth and regression. Am J Path 147:339–351.
  • Boon LM, Enjolras O, Mulliken JB. (1996). Congen-ital hemangioma: Evidence of accelerated involution. J Pediatr 128:329–335.
  • Dethlefsen SM, Mulliken JB, Glowacki J. (1986). An ultrastructural study of mast cell interactions in hem-angiomas Ultrastruct Path 10:175–183.
  • Folkman J. (1995). Clinical applications of research on angiogenesis. N Engl J Med 333:1757–1763.
  • Gavrieli Y, Sherman Y, Ben-Sasson S. A. (1992). Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493–501.
  • Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. (1984). Cell cycle analysis of a cell pro-liferation-associated human nuclear antigen defined by monoclonal antibody Ki-67. J Immunol 133:1710–1715.
  • Hanahan D, Folkman J. (1996). Patterns and emerg-ing mechanisms of the angiogenic switch during tu-morigenesis. Cell 86:353–364.
  • Holmgren L, O'Reilly MS, Folkman J. (1995). Dor-mancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis sup-pression. Nature Med 1:149–153.
  • Iwata J, Sonobe H, Furihata M, Ido E, Ohtsuki Y. (1996). High frequency of apoptosis in infantile cap-illary hemangioma. J Path 179:403–408.
  • Kra-ling BM, Razon MJ, Boon L.M, Zurakowski D, Seachord C, Darveau R P. Mulliken JB, Corless CL, Bischoff J. (1996). E-selectin is present in proliferat-ing endothelial cells in human hemangiomas. Am J Path 148:1181–1191.
  • Mancini AJ, Smoller BR. (1996). Proliferation and apoptosis within juvenile capillary hemangiomas. Am J Dermatopathol 18:505–514.
  • Mulliken JB., Young AE. (1988). Vascular birth-marks: Hemangiomas and malformations. WB Saun-ders. Philadelphia,PA.
  • Mulliken JB, Glowacki, J. (1982). Hemangiomas and vascular malformations in infants and children: Clas-sification based on endothelial characteristics. Plast Reconstr Surg 69:412–423.
  • O'Reilly MS, Holmgren L, Chen C, Folkman J. (1996). Angiostatin induces and sustains dormancy of human primary tumors in mice. Nature Med 2: 689–692.
  • Parangi S. O'Reilly M, Christofori G, Holmgren L, Grosfeld J, Folkman J, Hanahan D. (1996). Antian-giogenic therapy of transgenic mice impairs de novo tumor growth. Proc Nall Acad Sci USA 93:2002–2007.
  • Takahashi K, Mulliken JB, Kozakewich HPW, Rogers RA, FolkmanJ, Ezekowitz RAB. (1994). Cellular markers that distinguish the phasesofhemangioma during infancy and childhood. J Clin Invest 93:2357–2364.
  • Vaux DL, Strasser A. (1996). The molecular biology of apoptosis. Proc Nall Acad Sci USA 93:2239–2244.
  • WeidnerN.(1995). Intratumoral microvessel density as a prognostic factor in cancer. Am J Path 147:9–19.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.